VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $2 | -99.8% | 57 | +1.8% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 56 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $2,000 | 0.0% | 56 | -1.8% | 0.00% | 0.0% |
Q1 2022 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,000 | 0.0% | 57 | +1.8% | 0.00% | 0.0% |
Q3 2021 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,000 | 0.0% | 56 | -44.6% | 0.00% | 0.0% |
Q1 2018 | $2,000 | 0.0% | 101 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $2,000 | 0.0% | 101 | +1.0% | 0.00% | 0.0% |
Q3 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,000 | -98.0% | 100 | -97.7% | 0.00% | -98.4% |
Q1 2017 | $98,000 | +3.2% | 4,279 | -5.8% | 0.06% | -4.6% |
Q4 2016 | $95,000 | -78.7% | 4,542 | -73.2% | 0.06% | -82.1% |
Q3 2016 | $447,000 | – | 16,927 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |